CAH · Cardinal Health Inc · Documents

$281.10 +2.96 (+1.06%) At close · Nov 13 Play latest call Q1 2027 earnings call transcript

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$64.97B

231.14M

Volume · Nov 13 1.26M Avg daily vol (3M) 1.71M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2023

Feb 2

Earnings call

Q2 2023 earnings call

Feb 2

Current report 8-K

Financial results, Regulation FD disclosure

Feb 2

Quarterly report 10-Q FY2023 Q2, ended Dec 31

Quarterly report for FY2023 Q2

Revenue $51.47B ▲ 13.2% Net loss $130M

2022

Dec 19

Current report 8-K Events of Dec 16

Director or officer change, or executive pay, Regulation FD disclosure

Nov 10

Current report 8-K Events of Nov 9

Shareholder vote results

Nov 8

Registration statement S-3ASR

Registration statement

Nov 4

Earnings call

Q1 2023 earnings call

Nov 4

Current report 8-K

Financial results, Regulation FD disclosure

Nov 4

Quarterly report 10-Q FY2023 Q1, ended Sep 30

Quarterly report for FY2023 Q1

Revenue $49.6B ▲ 12.8% Net income $110M ▼ 59.4% Diluted EPS $0.40 ▼ 57.4%

Oct 4

Current report 8-K Events of Sep 30

Entered into a material agreement

Sep 28

Proxy statement DEF 14A Meeting Nov 9, 2022

Proxy statement

Sep 28

Proxy statement DEFA14A

Proxy statement

Sep 13

Current report 8-K

Regulation FD disclosure

Sep 8

Current report 8-K Events of Sep 7

Director or officer change, or executive pay, Regulation FD disclosure

Sep 6

Current report 8-K Events of Sep 5

Entered into a material agreement, Director or officer change, or executive pay, Regulation FD disclosure

Aug 11

Earnings call

Q4 2022 earnings call

Aug 11

Current report 8-K

Financial results, Regulation FD disclosure

Aug 11

Current report 8-K Events of Aug 7

Director or officer change, or executive pay, Regulation FD disclosure

Aug 11

Annual report 10-K FY2022, ended Jun 30

Annual report for FY2022

Revenue $181.36B ▲ 11.6% Net loss $933M Diluted EPS -$3.35

Jul 22

Current report 8-K Events of Jul 18

Other events

May 5

Earnings call

Q3 2022 earnings call

May 5

Current report 8-K

Financial results, Regulation FD disclosure

May 5

Quarterly report 10-Q FY2022 Q3, ended Mar 31

Quarterly report for FY2022 Q3

Revenue $44.84B ▲ 14.2% Net loss $1.39B

Feb 25

Current report 8-K

Entered into a material agreement, Regulation FD disclosure

Feb 3

Earnings call

Q2 2022 earnings call

Feb 3

Current report 8-K

Financial results, Regulation FD disclosure

Feb 3

Quarterly report 10-Q FY2022 Q2, ended Dec 31

Quarterly report for FY2022 Q2

Revenue $45.46B ▲ 9.4% Net income $49M ▼ 92.2%

Jan 10

Current report 8-K

Regulation FD disclosure

2021

Nov 9

Earnings call

Q1 2022 earnings call

Nov 9

Current report 8-K

Financial results, Regulation FD disclosure

Nov 9

Current report 8-K Events of Nov 5

Director or officer change, or executive pay, Shareholder vote results

Nov 9

Quarterly report 10-Q FY2022 Q1, ended Sep 30

Quarterly report for FY2022 Q1

Revenue $43.97B ▲ 12.6% Net income $271M Diluted EPS $0.94

Oct 25

Proxy statement DEFA14A

Proxy statement

Sep 23

Proxy statement DEF 14A Meeting Nov 5, 2021

Proxy statement

Sep 23

Proxy statement DEFA14A

Proxy statement

Sep 10

Proxy statement PRE 14A Meeting Nov 5, 2021

Proxy statement

Aug 16

Annual report 10-K FY2021, ended Jun 30

Annual report for FY2021

Revenue $162.47B ▲ 6.2% Net income $611M Diluted EPS $2.08

Aug 5

Earnings call

Q4 2021 earnings call

Aug 5

Current report 8-K

Financial results, Regulation FD disclosure

Jul 22

Current report 8-K Events of Jul 21

Other events

May 6

Earnings call

Q3 2021 earnings call

May 6

Current report 8-K

Financial results, Regulation FD disclosure

May 6

Quarterly report 10-Q FY2021 Q3, ended Mar 31

Quarterly report for FY2021 Q3

Revenue $39.28B ▲ 0.3% Net income $119M ▼ 66.0%

Apr 8

Current report 8-K Events of Apr 6

Benefit plan trading blackout

Apr 5

Current report 8-K Events of Mar 31

Director or officer change, or executive pay

Mar 12

Current report 8-K

Exit or restructuring costs, Material impairment, Regulation FD disclosure, Other events

Feb 5

Earnings call

Q2 2021 earnings call

Feb 5

Current report 8-K

Financial results, Regulation FD disclosure

Feb 5

Quarterly report 10-Q FY2021 Q2, ended Dec 31

Quarterly report for FY2021 Q2

Revenue $41.54B ▲ 4.5% Net income $629M ▲ 185.9%

2020

Nov 9

Current report 8-K/A Events of Jun 24

Director or officer change, or executive pay, Shareholder vote results

Showing 101–150 of 170 documents

Key facts CIK 721371 CUSIP 14149Y108 13F (30d) 1184 filings 1112 filers Visit website Investor relations